Literature DB >> 808033

Immune lysis of Sindbis virus.

V Stollar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 808033     DOI: 10.1016/0042-6822(75)90235-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  12 in total

1.  Fate of rubella genome ribonucleic acid after immune and nonimmune virolysis in the presence of ribonuclease.

Authors:  A Schluederberg; C Ajello; B Evans
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

2.  Form-determining functions in Sindbis virus nucleocapsids: nucleosomelike organization of the nucleocapsid.

Authors:  K M Coombs; D T Brown
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  Irreversible conversion of the physical state of herpes simplex virus preceding inactivation by thermal or antibody treatment.

Authors:  K Yanagi
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

Review 4.  The complement system: its importance in the host response to viral infection.

Authors:  R L Hirsch
Journal:  Microbiol Rev       Date:  1982-03

5.  The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus.

Authors:  W A Boere; B J Benaissa-Trouw; T Harmsen; T Erich; C A Kraaijeveld; H Snippe
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

6.  Divergent envelope E2 alphavirus sequences spanning amino acids 297 to 352 induce in mice virus-specific protective immunity and antibodies with complement-mediated cytolytic activity.

Authors:  H Grosfeld; S Lustig; Y Gozes; B Velan; S Cohen; M Leitner; B Lachmi; D Katz; U Olshevski; A Shafferman
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

7.  Studies of immune responses during recovery from Sindbis virus encephalitis in selectively reconstituted, thymectomized, lethally irradiated mice.

Authors:  M M Park; D E Griffin; R T Johnson
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

8.  Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5.

Authors:  Mohammed Rafii-El-Idrissi Benhnia; Megan M McCausland; John Laudenslager; Steven W Granger; Sandra Rickert; Lilia Koriazova; Tomoyuki Tahara; Ralph T Kubo; Shinichiro Kato; Shane Crotty
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

9.  Evaluation of the Galalpha1-3Gal epitope as a host modification factor eliciting natural humoral immunity to enveloped viruses.

Authors:  R M Welsh; C L O'Donnell; D J Reed; R P Rother
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

10.  Unusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine.

Authors:  Mohammed Rafii-El-Idrissi Benhnia; Matthew Maybeno; David Blum; Rowena Aguilar-Sino; Michael Matho; Xiangzhi Meng; Steven Head; Philip L Felgner; Dirk M Zajonc; Lilia Koriazova; Shinichiro Kato; Dennis R Burton; Yan Xiang; James E Crowe; Bjoern Peters; Shane Crotty
Journal:  J Virol       Date:  2012-11-14       Impact factor: 6.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.